MATAWAN, N.J. & EUGENE, Ore., October 14, 2025--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) ("Apimeds") today announced the expansion of the Apimeds ai ² Futures Lab program through ...
LA JOLLA, Calif. & ATHENS, Ga., February 03, 2026--(BUSINESS WIRE)--Lōkahi Therapeutics today announced the participation of the University of Georgia’s Student Industry Fellows Program in its ai² ...
MATAWAN, N.J. & MOSCOW, Idaho--(BUSINESS WIRE)-- Apimeds Pharmaceuticals US, Inc. (APUS) (“Apimeds”) today announced the expansion of its ai² Futures Lab™ program through a new collaboration with the ...
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the expansion of its ai² Futures Lab™ program through a new collaboration with the University of Idaho College of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results